elegant software that guides successful drug discovery
elegant software that guides successful drug discovery
innovative
drug discovery
technology
The Optibrium team works at the forefront of decision-analysis and predictive modelling research, developing innovative products that enhance the efficiency and productivity of drug discovery.
Software Solutions
Our Products
StarDropâ„¢ is a complete package of fully integrated, elegant software for small molecule design, optimisation and data analysis.
Enhance your expertise with artificial intelligence to make better decisions
A proven artificial intelligence platform for active learning in drug discovery
Keep up to date
News & Events
Prediction of In Vivo Pharmacokinetic Parameters and Time− Exposure Curves in Rats Using Machine Learning from the Chemical Structure
Prediction of In Vivo Pharmacokinetic Parameters and Time− Exposure Curves in Rats Using Machine Learning from the Chemical Structure  Published in Molecular Pharmaceutics, the paper describes the particularly challenging use of Alchemite to predict in vivo ... Read More
Early Development Medicinal Chemistry: Utilising Data and Artificial Intelligence
Early Development Medicinal Chemistry: Utilizing Data and Artificial Intelligence  In this Pharmaceutical Technology article, Meg Rivers interviews Optibrium's Chase Smith and Verseon's Kevin Short to discuss what data to consider when selecting a high-potential ... Read More
Optibrium Adds Augmented Intelligence for Compound Design to its StarDrop Small Molecule Drug Discovery Software
Optibrium Adds Augmented Intelligence for Compound Design to its StarDrop Small Molecule Drug Discovery Software  New Inspyra™ module combines chemists’ expertise with exploratory capabilities of automated compound design. Inspyra™ provides drug designers direct ... Read More
Â
Our next webinar
AI in early Drug Discovery: From Promise to Practice
Join, Jeff Blaney (Genentech), Darren Green (GSK), Julian Levell (New Equilibrium), Matt Segall (Optibrium) who will discuss the state of AI in early drug discovery from hit to preclinical candidate and share their experiences with and expectations of AI.
Join The
Optibrium Community
Access a wealth of information on all of our products, learn more about our science and our wider community of collaborators.
Learn More
About Us
Founded in 2009, Optibrium continues to develop new products and research novel technologies to improve the efficiency and productivity of drug discovery. Optibrium works closely with its broad range of customers and collaborators that include leading global pharma, agrochemical and flavouring companies, biotechs and academic groups.
Got an Enquiry?
Get In Touch
If you are interested in finding out more about Optibrium or any of our products or services, please do not hesitate to contact us using the contact form. Further details on our office locations and other contact details can be found on our Contact page.